We Love Pharma | Regulations meet Business

The EU “Pharma Package” is the most substantial overhaul of medicines legislation in more than 20 years. The political agreement reached on 11 December 2025 confirms the baseline protection model with capped extensions, a broadened Bolar exemption enabling full “day-one” readiness, including participation in procurement tenders, and strengthened supply security obligations. Although formal adoption and national transposition are still pending, the legislative objective is clear: to establish streamlined pathways for immediate post-exclusivity market entry, coupled with enhanced obligations to prevent and manage shortages.

How is this reshaping market entry dynamics, shortage obligations, and regulatory procedures in ways that affect the generics and biosimilars sector?

Join us for a focused discussion and practical takeaways.

Reserve your place by emailing office.bulgaria@schoenherr.eu or yo.pencheva@schoenherr.eu. 

Program

16:30 Registration and welcome drink

17:00 Navigating Change in Pharma: Reform, Regulation and Advertising Compliance - Hristo Hadzhiiliev, Schoenherr

17:20 Panel Discussion: Reimbursement Under Pressure—What Needs to Change? 
Panelists:
Vladimir Afenliev
Tbc
Moderator: Elena Todorova, Schoenherr

17:50 M&A Case Study – How to buy a retailer? – Gergana Roussinova-Ivanova, Schoenherr

18:00 Networking and Cocktails